Pre-market hot trades in US stocks: Focus Universal up 7.46% pre-market; Salesforce down 4.77% pre-market

Popular Pre-Market Trades in U.S. Stocks

Focus Universal, up 7.46% in pre-market, has no significant news recently. Trading is active with clear capital flows. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Salesforce is down 4.77% in pre-market. Based on recent news,

1. On July 14, Salesforce announced its Agentforce ARR grew 205% to $1.2 billion and plans a new $50 billion repurchase authorization. This news indicates the company's deep undervaluation in the AI field, driving the stock price up, but the market remains skeptical about its future profitability, leading to stock price fluctuations.

2. On July 14, analyst Borges pointed out that Salesforce's "headless" and agent-based monetization methods are emerging, with Slack being an early beneficiary. She also mentioned that Salesforce plans to acquire Fin, which will strengthen its AI service assets, supporting its target price of $242 and buy rating. This news boosted market confidence but also raised concerns about integration risks.

3. On July 14, market analysis showed that Salesforce's current price-to-earnings ratio is 12 times, indicating relative undervaluation. However, there are discrepancies in market expectations regarding its future profitability and AI growth, leading to stock price fluctuations. The overall performance of the tech sector is weak, affecting Salesforce's stock price.

Top Gainers in U.S. Pre-Market

NextCure is up 389.45% in pre-market, based on recent key news:

1. On July 14, NextCure announced a merger with Avere Therapeutics, causing a significant stock price increase. After the merger, the company will operate under the name Avere Therapeutics and plans to develop the AVR-001 drug through $320 million financing, driving the stock price up by 93%. Source: Reuters

2. On July 14, Hansoh Pharmaceutical announced participation in Avere's directed issuance and granted it exclusive licensing. This move accelerates the development of AVR-001, expected to enhance product value and drive NextCure's stock price up. Source: Zhitong Finance

3. On July 14, NextCure shareholders will receive rights to 90% of potential transaction proceeds. This right increases investor confidence, further driving the stock price up. Source: CNBC The biotechnology industry has seen frequent merger activities recently, with significant capital inflows.

Shuttle Pharmaceuticals is up 44.32% in pre-market, based on recent news:

1. On July 13, HRT Financial LP increased its direct holdings in Shuttle Pharmaceuticals to 61,271 shares. HRT Financial purchased 8,997 shares in the open market at prices ranging from $3.11 to $3.38 per share. This news indicates enhanced confidence from institutional investors in the company, significantly driving the stock price up On July 13, HRT Financial reported in Form 3 that it holds 10% of Shuttle Pharmaceuticals. The document shows that as of July 9, HRT Financial directly held 60,540 shares of common stock. This disclosure of holdings further enhanced market confidence in the company, leading to a rise in stock prices. The market reacted positively to the increase in institutional holdings.

Picard Medical rose 32.70% in pre-market trading. Based on recent key news:

1. On July 14, Picard Medical's stock price increased by 32.70% in pre-market trading. The company did not release any related announcements or news, and the reason for the stock price increase remains unclear.

2. On July 14, eLong Power Holding announced the completion of a $6.6 million public offering, and its stock price fell 15% in pre-market trading. This move may raise concerns in the market about the company's future financing capabilities.

3. On July 14, Telefonaktiebolaget LM Ericsson's stock price fell 9.2% in pre-market trading after the announcement of its second-quarter results. The performance did not meet market expectations, leading to a decline in investor confidence. Market volatility is significant, and macroeconomic dynamics need to be monitored